Product NDC: | 0115-1208 |
Proprietary Name: | DOXYCYCLINE HYCLATE |
Non Proprietary Name: | DOXYCYCLINE HYCLATE |
Active Ingredient(s): | 75 mg/1 & nbsp; DOXYCYCLINE HYCLATE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0115-1208 |
Labeler Name: | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090505 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110411 |
Package NDC: | 0115-1208-01 |
Package Description: | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (0115-1208-01) |
NDC Code | 0115-1208-01 |
Proprietary Name | DOXYCYCLINE HYCLATE |
Package Description | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (0115-1208-01) |
Product NDC | 0115-1208 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | DOXYCYCLINE HYCLATE |
Dosage Form Name | TABLET, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20110411 |
Marketing Category Name | ANDA |
Labeler Name | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
Substance Name | DOXYCYCLINE HYCLATE |
Strength Number | 75 |
Strength Unit | mg/1 |
Pharmaceutical Classes |